| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.092 | 0.003 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.13 | 0.003 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |